Kuo et al. [40] applied the TLR-4 antagonist eritoran in the colon of CD14 + TLR4 + wild-type mice with chemically induced CRC and found that apoptosis in tumor cells was significantly enhanced, and CRC growth was reduced. This evidence concerns the gene TLR4 and colorectal carcinoma.